Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00741637
Recruitment Status : Completed
First Posted : August 26, 2008
Last Update Posted : March 30, 2012
Vaccine Technologies Inc.
Siriraj Hospital
Information provided by (Responsible Party):
International Vaccine Institute

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2011
  Actual Study Completion Date : June 2011